source
- Endpoints 11 showcases top biotech startups, signaling renewed optimism and fundingThe Endpoints 11 awards highlight the most promising biotech startups of 2026, offering a snapshot of emerging trends in the sector. According to the summary, the awards illustrate that biotech ap…
- Kali Therapeutics pivots from Chinese drug acquisitions to focus on its own growing pipelineKali Therapeutics, the winner of the Endpoints 11 2026 competition, initially explored the possibility of purchasing drug candidates from China. The company ultimately chose to rely on its own res…